BMO raised Methanex's price target to $70, citing 31.5% upside, despite Q4 loss and revenue miss.

BMO Capital Markets raised Methanex's price target to $70 from $65, maintaining an "outperform" rating, citing potential 31.5% upside. The company reported a Q4 loss of $0.14 per share, missing estimates by $0.95, and revenue of $968.81 million, below the $1.03 billion consensus, though up 2.1% year-over-year. Analysts forecast $4.32 EPS for the year. Methanex declared a quarterly dividend of $0.185 per share, yielding 1.4%. The stock closed at $53.38 on March 18, 2026, with a market cap of $4.11 billion and a beta of 0.65. Multiple brokerages, including UBS and RBC, have issued positive ratings.